drugset / Trial / NCT01646489
Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and affect on blood levels of miravirsen and telaprevir when administered together.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miravirsen | Antisense oligonucleotide | 7 mg/kg | Subcutaneous |
| Comparator | Telaprevir | Small molecule | 750 mg | Oral |